Hypercalcemia of malignancy and new treatment options

References

• HorwitzMHodakSStewartANon-parathyroid hypercalcemiaFavusMPrimer on the Metabolic Bone Diseases and Disorders of Mineral MetabolismWashington, DCAmerican Society of Bone and Mineral Research2008307312
   Google Scholar
• StewartAFClinical practice. Hypercalcemia associated with cancerNew Engl J Med2005352437337915673803
   PubMed Web of Science ®Google Scholar
• RosnerMHDalkinACOnco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemiaClin J Am Soc Nephrol20127101722172922879438
   PubMed Web of Science ®Google Scholar
• BurtMEBrennanMFIncidence of hypercalcemia and malignant neoplasmArch Surg198011567047077387355
   PubMedGoogle Scholar
• Vassilopoulou-SellinRNewmanBMTaylorSHGuineeVFIncidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer centerCancer1993714130913128382106
   PubMed Web of Science ®Google Scholar
• KyleRAGertzMAWitzigTEReview of 1027 patients with newly diagnosed multiple myelomaMayo Clin Proc2003781213312528874
   PubMed Web of Science ®Google Scholar
• StewartABroadusAMalignancy Associated HypercalcemiaDeGrootLJamesonJEndocrinology 25th edPhiladelphiaSaunders-Elsevier200615551565
   Google Scholar
• InzucchiSEUnderstanding hypercalcemia. Its metabolic basis, signs, and symptomsPostgrad Med2004115469703615095538
   PubMed Web of Science ®Google Scholar
• CarnailleBOudarCPattouFCombemaleFRochaJProyeCPancreatitis and primary hyperparathyroidism: forty casesAust N Z J Surg19986821171199494002
   PubMedGoogle Scholar
• LeviMEllisMABerlTControl of renal hemodynamics and glomerular filtration rate in chronic hypercalcemia. Role of prostaglandins, renin-angiotensin system, and calciumJ Clin Invest1983716162416326345587
   PubMed Web of Science ®Google Scholar
• SeymourJFGagelRFCalcitriol: the major humoral mediator of hypercalcemia in Hodgkin’s disease and non-Hodgkin’s lymphomasBlood1993825138313948364192
   PubMed Web of Science ®Google Scholar
• RoodmanGDMechanisms of bone metastasisNew Engl J Med2004350161655166415084698
   PubMed Web of Science ®Google Scholar
• ColemanRESeamanJJThe role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastasesSemin Oncol2001282 Suppl 6111611346860
   PubMed Web of Science ®Google Scholar
• Abou-SamraABJuppnerHForceTExpression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calciumProc Natl Acad Sci U S A1992897273227361313566
   PubMed Web of Science ®Google Scholar
• GuiseTAYinJJTaylorSDEvidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysisJ Clin Invest1996987154415498833902
   PubMed Web of Science ®Google Scholar
• MundyGRRaiszLGCooperRASchechterGPSalmonSEEvidence for the secretion of an osteoclast stimulating factor in myelomaNew Engl J Med197429120104110464413338
   PubMed Web of Science ®Google Scholar
• ChoiSJCruzJCCraigFMacrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myelomaBlood200096267167510887133
   PubMed Web of Science ®Google Scholar
• Case Records of the Massachusetts General Hospital (Case 27461)New Engl J Med194122520789791
   Google Scholar
• GellhornAPlimptonCHHypercalcemia in malignant disease without evidence of bone destructionAm J Med195621575075913362306
   PubMedGoogle Scholar
• LaffertyFWPseudohyperparathyroidismMedicine (Baltimore)19664532472605327243
   PubMed Web of Science ®Google Scholar
• PhilbrickWMWysolmerskiJJGalbraithSDefining the roles of parathyroid hormone-related protein in normal physiologyPhysiol Rev19967611271738592727
   PubMed Web of Science ®Google Scholar
• BurtisWJBradyTGOrloffJJImmunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancerNew Engl J Med199032216110611122320080
   PubMed Web of Science ®Google Scholar
• BudayrAANissensonRAKleinRFIncreased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemiaAnn Intern Med1989111108078122817628
   PubMed Web of Science ®Google Scholar
• OrloffJJWuTLStewartAFParathyroid hormone-like proteins: biochemical responses and receptor interactionsEndocr Rev19891044764952558877
   PubMed Web of Science ®Google Scholar
• BenderRAHansenHHypercalcemia in bronchogenic carcinoma. A prospective study of 200 patientsAnn Intern Med19748022052084359740
   PubMed Web of Science ®Google Scholar
• AdamiSRossiniMHypercalcemia of malignancy: pathophysiology and treatmentBone199213Suppl 1S51S551581120
   PubMedGoogle Scholar
• NakayamaKFukumotoSTakedaSDifferences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemiaJ Clin Endocrinol Metab19968126076118636276
   PubMed Web of Science ®Google Scholar
• Vacher-CoponatHOprisADenizotADussolBBerlandYHypercalcaemia induced by excessive parathyroid hormone secretion in a patient with a neuroendocrine tumourNephrol Dial Transplant200520122832283516188904
   PubMed Web of Science ®Google Scholar
• HibiMHaraFTomishigeH1,25-dihydroxyvitamin D-mediated hypercalcemia in ovarian dysgerminomaPediatr Hematol Oncol2008251737818231957
   PubMed Web of Science ®Google Scholar
• ChristakosSAjibadeDVDhawanPFechnerAJMadyLJVitamin D: metabolismEndocrinol Metab Clin North Am2010392243253 table of contents20511049
   PubMed Web of Science ®Google Scholar
• HewisonMKantorovichVLikerHRVitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophagesJ Bone Miner Res200318357958212619944
   PubMed Web of Science ®Google Scholar
• NakajimaKTamaiMOkaniwaSHumoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literatureEndocr J201360555756223303131
   PubMed Web of Science ®Google Scholar
• YoshimotoKYamasakiRSakaiHEctopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemiaJ Clin Endocrinol Metab19896859769812541161
   PubMed Web of Science ®Google Scholar
• NussbaumSRGazRDArnoldAHypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormoneNew Engl J Med199032319132413282215618
   PubMed Web of Science ®Google Scholar
• WongKTsudaSMukaiRSumidaKArakakiRParathyroid hormone expression in a patient with metastatic nasopharyngeal rhabdomyosarcoma and hypercalcemiaEndocrine2005271838616077176
   PubMed Web of Science ®Google Scholar
• LaffertyFWDifferential diagnosis of hypercalcemiaJ Bone Miner Res19916Suppl 2S51S59 discussion S611763670
   PubMedGoogle Scholar
• ReaganPPaniARosnerMHApproach to diagnosis and treatment of hypercalcemia in a patient with malignancyAm J Kidney Dis201463114114724021907
   PubMed Web of Science ®Google Scholar
• HutchessonACBundredNJRatcliffeWASurvival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidismPostgrad Med J19957183128317708588
   PubMed Web of Science ®Google Scholar
• StrodelWEThompsonNWEckhauserFEKnolJAMalignancy and concomitant primary hyperparathyroidismJ Surg Oncol198837110123336214
   PubMed Web of Science ®Google Scholar
• CasezJPfammatterRNguyenQLippunerKJaegerPDiagnostic approach to hypercalcemia: relevance of parathyroid hormone and parathyroid hormone-related protein measurementsEur J Intern Med200112434434911395297
   PubMedGoogle Scholar
• BilezikianJPManagement of acute hypercalcemiaNew Engl J Med199232618119612031532633
   PubMed Web of Science ®Google Scholar
• DavidsonTGConventional treatment of hypercalcemia of malignancyAm J Health Syst Pharm200158Suppl 3S8S1511757206
   PubMedGoogle Scholar
• HoskingDJCowleyABucknallCARehydration in the treatment of severe hypercalcaemiaQ J Med1981502004734817342172
   PubMedGoogle Scholar
• LeGrandSBLeskuskiDZamaINarrative review: furosemide for hypercalcemia: an unproven yet common practiceAnn Intern Med2008149425926318711156
   PubMed Web of Science ®Google Scholar
• VaughnCBVaitkeviciusVKThe effects of calcitonin in hypercalcemia in patients with malignancyCancer1974344126812714472732
   PubMed Web of Science ®Google Scholar
• DeftosLJFirstBPCalcitonin as a drugAnn Intern Med19819521921977258871
   PubMed Web of Science ®Google Scholar
• PurdueBWTilakaratneNSextonPMMolecular pharmacology of the calcitonin receptorReceptors Channels200283–424325512529940
   PubMedGoogle Scholar
• CaranoATeitelbaumSLKonsekJDSchlesingerPHBlairHCBisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitroJ Clin Invest19908524564612105340
   PubMed Web of Science ®Google Scholar
• RogersMJGordonSBenfordHLCellular and molecular mechanisms of action of bisphosphonatesCancer20008812 Suppl2961297810898340
   PubMedGoogle Scholar
• NussbaumSRYoungerJVandepolCJSingle-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosagesAm J Med19939532973048368227
   PubMed Web of Science ®Google Scholar
• GreenJR MKJaegggiKAPreclinical pharmacoloyg of CGP 42446 a new potent heterocyclic bisphosphonate compoundJ Bone Miner Res199497457518053405
   PubMed Web of Science ®Google Scholar
• DunfordJEThompsonKCoxonFPStructure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonatesJ Pharmacol Exp Ther2001296223524211160603
   PubMed Web of Science ®Google Scholar
• MajorPLortholaryAHonJZoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trialsJ Clin Oncol200119255856711208851
   PubMed Web of Science ®Google Scholar
• Pharmaceutical Partners of Canada Inc. (Pamidronate) [package insert]Richmond Hill, ONPharmaceutical Partners of Canada Inc2010 Available from: http://fresenius-kabi.ca/wp-content/uploads/2015/01/EN_Web_Insert_Pamid_NL.pdfAccessed July 8, 2015
   Google Scholar
• TanvetyanonTStiffPJManagement of the adverse effects associated with intravenous bisphosphonatesAnn Oncol200617689790716547070
   PubMed Web of Science ®Google Scholar
• PerazellaMAMarkowitzGSBisphosphonate nephrotoxicityKidney Int200874111385139318685574
   PubMed Web of Science ®Google Scholar
• KyleRAYeeGCSomerfieldMRAmerican Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myelomaJ Clin Oncol200725172464247217515569
   PubMed Web of Science ®Google Scholar
• Zometa Available from: https://www.pharma.us.novartis.com/product/pi/pdf/Zometa.pdfAccessed July 8, 2015
   Google Scholar
• SantarpiaLKochCASarlisNJHypercalcemia in cancer patients: pathobiology and managementHorm Metab Res201042315316419960404
   PubMed Web of Science ®Google Scholar
• CvitkovicFArmandJPTubiana-HulinMRossiJFWarrellRPJrRandomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemiaCancer J2006121475316613662
   PubMed Web of Science ®Google Scholar
• KaiserWBiesenbachGKramarRZazgornikJCalcium free hemodialysis: an effective therapy in hypercalcemic crisis – report of 4 casesIntensive Care Med19891574714742600293
   PubMed Web of Science ®Google Scholar
• KooWSJeonDSAhnSJKimYSYoonYSBangBKCalcium-free hemodialysis for the management of hypercalcemiaNephron19967234244288852491
   PubMed Web of Science ®Google Scholar
• LeeheyDJIngTSCorrection of hypercalcemia and hypophosphatemia by hemodialysis using a conventional, calcium-containing dialysis solution enriched with phosphorusAm J Kidney Dis19972922882909016904
   PubMed Web of Science ®Google Scholar
• CastellanoDSepulvedaJMGarcia-EscobarIRodriguez-AntolinASundlovACortes-FunesHThe role of RANK-ligand inhibition in cancer: the story of denosumabOncologist201116213614521285392
   PubMed Web of Science ®Google Scholar
• HuMIGlezermanIGLeboulleuxSDenosumab for treatment of hypercalcemia of malignancyJ Clin Endocrinol Metab20149993144315224915117
   PubMed Web of Science ®Google Scholar
• LiptonAFizaziKStopeckATSuperiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trialsEur J Cancer201248163082309222975218
   PubMed Web of Science ®Google Scholar
• AutioKAFarookiAGlezermanIGSevere hypocalcemia associated with denosumab in metastatic castration-resistant prostate cancer: risk factors and precautions for treating physiciansClin Genitourin Cancer2015134e305e30925559408
   PubMed Web of Science ®Google Scholar
• CicciJDBuieLBatesJvan DeventerHDenosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunctionClin Lymphoma Myeloma Leuk2014146e207e21125128013
   PubMedGoogle Scholar
• MessaPAlfieriCBrezziBClinical utilization of cinacalcet in hypercalcemic conditionsExpert Opin Drug Metab Toxicol20117451752821361849
   PubMed Web of Science ®Google Scholar
• BrownEMLianJBNew insights in bone biology: unmasking skeletal effects of the extracellular calcium-sensing receptorSci Signal2008135pe4018765829
   PubMed Web of Science ®Google Scholar
• SilverbergSJRubinMRFaimanCCinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinomaJ Clin Endocrinol Metab200792103803380817666472
   PubMed Web of Science ®Google Scholar
• CampbellSRFlombaumCDGlezermanIGUse of cinacalcet for treatment of hypercalcemia of malignancy refractory to conventional therapies [Abstract]J Am Soc Nephrol201324614A
   Google Scholar
• OgataEParathyroid hormone-related protein as a potential target of therapy for cancer-associated morbidityCancer20008812 Suppl2909291110898333
   PubMedGoogle Scholar
• RalstonSHGallacherSJPatelUCampbellJBoyleITCancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patientsAnn Intern Med199011274995042138442
   PubMed Web of Science ®Google Scholar
• MundyGRMartinTJThe hypercalcemia of malignancy: pathogenesis and managementMetabolism19823112124712776755168
   PubMed Web of Science ®Google Scholar
• FiskenRAHeathDABoldAMHypercalcaemia – a hospital surveyQ J Med1980491964054187022540
   PubMedGoogle Scholar
• BlomqvistCPMalignant hypercalcemia – a hospital surveyActa Med Scand198622054554633812029
   PubMedGoogle Scholar
• DonovanPJAchongNGriffinKGalliganJPretoriusCJMcLeodDSPTHrP-mediated hypercalcemia: causes and survival in 138 patientsJ Clin Endocrinol Metab201510052024202925719931
   PubMed Web of Science ®Google Scholar